<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37680625</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Post-COVID symptoms are associated with endotypes reflecting poor inflammatory and hemostatic modulation.</ArticleTitle><Pagination><StartPage>1243689</StartPage><MedlinePgn>1243689</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1243689</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1243689</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Persistent symptoms after COVID-19 infection ("long COVID") negatively affects almost half of COVID-19 survivors. Despite its prevalence, its pathophysiology is poorly understood, with multiple host systems likely affected. Here, we followed patients from hospital to discharge and used a systems-biology approach to identify mechanisms of long COVID.</AbstractText><AbstractText Label="METHODS">RNA-seq was performed on whole blood collected early in hospital and 4-12 weeks after discharge from 24 adult COVID-19 patients (10 reported post-COVID symptoms after discharge). Differential gene expression analysis, pathway enrichment, and machine learning methods were used to identify underlying mechanisms for post-COVID symptom development.</AbstractText><AbstractText Label="RESULTS">Compared to patients with post-COVID symptoms, patients without post-COVID symptoms had larger temporal gene expression changes associated with downregulation of inflammatory and coagulation genes over time. Patients could also be separated into three patient endotypes with differing mechanistic trajectories, which was validated in another published patient cohort. The "Resolved" endotype (lowest rate of post-COVID symptoms) had robust inflammatory and hemostatic responses in hospital that resolved after discharge. Conversely, the inflammatory/hemostatic responses of "Suppressive" and "Unresolved" endotypes (higher rates of patients with post-COVID symptoms) were persistently dampened and activated, respectively. These endotypes were accurately defined by specific blood gene expression signatures (6-7 genes) for potential clinical stratification.</AbstractText><AbstractText Label="DISCUSSION">This study allowed analysis of long COVID whole blood transcriptomics trajectories while accounting for the issue of patient heterogeneity. Two of the three identified and externally validated endotypes ("Unresolved" and "Suppressive") were associated with higher rates of post-COVID symptoms and either persistently activated or suppressed inflammation and coagulation processes. Gene biomarkers in blood could potentially be used clinically to stratify patients into different endotypes, paving the way for personalized long COVID treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 An, Baghela, Zhang, Blimkie, Gauthier, Kaufmann, Acton, Lee, Levesque and Hancock.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>An</LastName><ForeName>Andy Yi</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baghela</LastName><ForeName>Arjun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peter G Y</ForeName><Initials>PGY</Initials><AffiliationInfo><Affiliation>Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blimkie</LastName><ForeName>Travis M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gauthier</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de microbiologie-infectiologie et d'immunologie, Universit&#xe9; de Laval, Laval, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufmann</LastName><ForeName>Daniel Elias</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McGill Genome Centre, Fonds de recherche du Qu&#xe9;bec (FRQ) COVID-19 Biobank, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acton</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Amy H Y</ForeName><Initials>AHY</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levesque</LastName><ForeName>Roger C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de microbiologie-infectiologie et d'immunologie, Universit&#xe9; de Laval, Laval, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hancock</LastName><ForeName>Robert E W</ForeName><Initials>REW</Initials><AffiliationInfo><Affiliation>Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FDN-154287</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006490">Hemostatics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006490" MajorTopicYN="Y">Hemostatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001777" MajorTopicYN="N">Blood Coagulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001826" MajorTopicYN="Y">Body Fluids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">endotypes</Keyword><Keyword MajorTopicYN="N">gene expression</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">personalized medicine</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>4</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37680625</ArticleId><ArticleId IdType="pmc">PMC10482103</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1243689</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Coronavirus Statistics . Worldometer. Available at: https://www.worldometers.info/coronavirus/.</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B, et al. . Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis (2022) 226:1593&#x2013;607. doi: 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM. &amp; Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet (2022) 400:452&#x2013;61. doi: 10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Tosto-Mancuso J, Wood J, Cortes M, Kontorovich A, McCarthy D, et al. . Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil (2022) 101:48&#x2013;52. doi: 10.1097/PHM.0000000000001910</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine (2021) 38:101019. doi: 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention . Long COVID or post-COVID conditions. Atlanta, USA: CDC;  (2022). Available at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID&#x2014;mechanisms, risk factors, and management. BMJ (2021) 374:n1648. doi: 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. . Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PloS Med (2021) 18:e1003773. doi: 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark DV, Kibuuka H, Millard M, Wakabi S, Lukwago L, Taylor A, et al. . Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis (2015) 15:905&#x2013;12. doi: 10.1016/S1473-3099(15)70152-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)70152-0</ArticleId><ArticleId IdType="pubmed">25910637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology (2010) 15:543&#x2013;50. doi: 10.1111/j.1440-1843.2010.01720.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2010.01720.x</ArticleId><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Slikke EC, An AY, Hancock REW, Bouma HR. Exploring the pathophysiology of post-sepsis syndrome to identify therapeutic opportunities. eBioMedicine (2020) 61:103044. doi: 10.1016/j.ebiom.2020.103044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103044</ArticleId><ArticleId IdType="pmc">PMC7544455</ArticleId><ArticleId IdType="pubmed">33039713</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskett WI, Qureshi AI, Shyu D, Armer JM, Shyu C-R. Covid-specific long-term sequelae in comparison to common viral respiratory infections: an analysis of 17,487 infected adult patients. Open Forum Infect Dis (2023) 10:ofac683. doi: 10.1093/ofid/ofac683</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac683</ArticleId><ArticleId IdType="pmc">PMC9846186</ArticleId><ArticleId IdType="pubmed">36686632</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM. The costs of long COVID. JAMA Health Forum (2022) 3:e221809. doi: 10.1001/jamahealthforum.2022.1809</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM, Summers LH. The COVID-19 pandemic and the $16 trillion virus. JAMA (2020) 324:1495&#x2013;6. doi: 10.1001/jama.2020.19759</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19759</ArticleId><ArticleId IdType="pmc">PMC7604733</ArticleId><ArticleId IdType="pubmed">33044484</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol (2022) 23:210&#x2013;6. doi: 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, et al. . The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. CR Med (2022) 3(6):100663. doi: 10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, et al. . Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med (2022) 54:1473&#x2013;87. doi: 10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, Rodr&#xed;guez Y, Acosta-Ampudia Y, Monsalve DM, Zhu C, Li QZ, et al. . Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med (2022) 20:129. doi: 10.1186/s12967-022-03328-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, et al. . Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms. Eur Respir J (2022) 61:2200970. doi: 10.1183/13993003.00970-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Piazza M, Boner AL, Bellanti JA. Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. Allergy Asthma Proc (2022) 43:187&#x2013;93. doi: 10.2500/aap.2022.43.220018</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2022.43.220018</ArticleId><ArticleId IdType="pmc">PMC9106095</ArticleId><ArticleId IdType="pubmed">35524358</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, et al. . Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med (N Y) (2022) 3:371&#x2013;387.e9. doi: 10.1016/j.medj.2022.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens (2021) 10:763. doi: 10.3390/pathogens10060763</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J (2022) 479:537&#x2013;59. doi: 10.1042/BCJ20220016</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, et al. . Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med (2022) 20:26. doi: 10.1186/s12916-021-02228-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson RC, Simons NW, Wilkins L, Cheng E, Del Valle DM, Hoffman GE, et al. . Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae. Nat Med (2023) 29:236&#x2013;246. doi: doi: 10.1038/s41591-022-02107-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02107-4</ArticleId><ArticleId IdType="pmc">PMC9873574</ArticleId><ArticleId IdType="pubmed">36482101</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay K, Rousseau S, Zawati MH, Auld D, Chass&#xe9; M, Coderre D, et al. . The Biobanque qu&#xe9;b&#xe9;coise de la COVID-19 (BQC19)-A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories. PloS One (2021) 16:e0245031. doi: 10.1371/journal.pone.0245031</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245031</ArticleId><ArticleId IdType="pmc">PMC8133500</ArticleId><ArticleId IdType="pubmed">34010280</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi R, Liu P. Sample size calculation while controlling false discovery rate for differential expression analysis with RNA-sequencing experiments. BMC Bioinform (2016) 17:146. doi: 10.1186/s12859-016-0994-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-016-0994-9</ArticleId><ArticleId IdType="pmc">PMC4815167</ArticleId><ArticleId IdType="pubmed">27029470</ArticleId></ArticleIdList></Reference><Reference><Citation>Baghela A, An A, Zhang P, Acton E, Gauthier J, Brunet-Ratnasingham E, et al. . Predicting severity in COVID-19 disease using sepsis blood gene expression signatures. Sci Rep (2023) 13:1247. doi: 10.1038/s41598-023-28259-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-28259-y</ArticleId><ArticleId IdType="pmc">PMC9868505</ArticleId><ArticleId IdType="pubmed">36690713</ArticleId></ArticleIdList></Reference><Reference><Citation>
Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data. Available at: https://www.bioinformatics.babraham.ac.uk/projects/fastqc/.</Citation></Reference><Reference><Citation>Ewels P, Magnusson M, Lundin S, K&#xe4;ller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics (2016) 32:3047&#x2013;8. doi: 10.1093/bioinformatics/btw354</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw354</ArticleId><ArticleId IdType="pmc">PMC5039924</ArticleId><ArticleId IdType="pubmed">27312411</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. . STAR: ultrafast universal RNA-seq aligner. Bioinformatics (2013) 29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Pyl PT, Huber W. HTSeq&#x2014;a Python framework to work with high-throughput sequencing data. Bioinformatics (2015) 31:166&#x2013;9. doi: 10.1093/bioinformatics/btu638</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu638</ArticleId><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol (2014) 15:550. doi: 10.1186/s13059-014-0550-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman GE, SChadt EE. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinform (2016) 17:483. doi: 10.1186/s12859-016-1323-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-016-1323-z</ArticleId><ArticleId IdType="pmc">PMC5123296</ArticleId><ArticleId IdType="pubmed">27884101</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabregat A, Sidiropoulos K, Viteri G, Forner O, Marin-Garcia P, Arnau V, et al. . Reactome pathway analysis: a high-performance in-memory approach. BMC Bioinform (2017) 18:142. doi: 10.1186/s12859-017-1559-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-017-1559-2</ArticleId><ArticleId IdType="pmc">PMC5333408</ArticleId><ArticleId IdType="pubmed">28249561</ArticleId></ArticleIdList></Reference><Reference><Citation>Foroushani ABK, Brinkman FSL, Lynn DJ. Pathway-GPS and SIGORA: identifying relevant pathways based on the over-representation of their gene-pair signatures. PeerJ (2013) 1:e229. doi: 10.7717/peerj.229</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.229</ArticleId><ArticleId IdType="pmc">PMC3883547</ArticleId><ArticleId IdType="pubmed">24432194</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A, Birger C, Thorvaldsd&#xf3;ttir H, Ghandi M, Mesirov JP, Tamayo P, et al. . The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst (2015) 1:417&#x2013;25. doi: 10.1016/j.cels.2015.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2015.12.004</ArticleId><ArticleId IdType="pmc">PMC4707969</ArticleId><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang L-G, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS (2012) 16:284&#x2013;7. doi: 10.1089/omi.2011.0118</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K, Studer M, et al. . cluster: cluster analysis basics and extensions. (2022).</Citation></Reference><Reference><Citation>Arora P. Deepali &amp; Varshney, S. Analysis of k-means and k-medoids algorithm for big data. Proc Comput Sci (2016) 78:507&#x2013;12. doi: 10.1016/j.procs.2016.02.095</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.procs.2016.02.095</ArticleId></ArticleIdList></Reference><Reference><Citation>Baghela A, Pena OM, Lee AH, Baquir B, Falsafi R, An A, et al. . Predicting sepsis severity at first clinical presentation: the role of endotypes and mechanistic signatures. eBioMedicine (2022) 75:103776. doi: 10.1016/j.ebiom.2021.103776</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103776</ArticleId><ArticleId IdType="pmc">PMC8808161</ArticleId><ArticleId IdType="pubmed">35027333</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman JH, Hastie T, TibshIrani R. Regularization paths for generalized linear models via coordinate descent. J Stat Soft (2010) 33:1&#x2013;22. doi: 10.18637/jss.v033.i01</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v033.i01</ArticleId><ArticleId IdType="pmc">PMC2929880</ArticleId><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform (2013) 14:7. doi: 10.1186/1471-2105-14-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-7</ArticleId><ArticleId IdType="pmc">PMC3618321</ArticleId><ArticleId IdType="pubmed">23323831</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol (2018) 1711:243&#x2013;59. doi: 10.1007/978-1-4939-7493-1_12</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7493-1_12</ArticleId><ArticleId IdType="pmc">PMC5895181</ArticleId><ArticleId IdType="pubmed">29344893</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC, Murthy S, Diaz J, Adhikari NK, Angus DC, Arabi YM, et al. . A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis (2020) 20:e192&#x2013;7. doi: 10.1016/S1473-3099(20)30483-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson RC, Simons NW, Wilkins L, Cheng E, Del Valle DM, Hoffman GE, et al. . Acute COVID-19 gene-expression profiles show multiple etiologies of long-term sequelae. medRxiv (2021) 2021:10.04.21264434. doi: 10.1101/2021.10.04.21264434</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.04.21264434</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrera FJ, Shekhar S, Wurth R, Moreno-Pena PJ, Ponce OJ, Hajdenberg M, et al. . Prevalence of diabetes and hypertension and their associated risks for poor outcomes in COVID-19 patients. J Endocr Soc (2020) 4:bvaa102. doi: 10.1210/jendso/bvaa102</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvaa102</ArticleId><ArticleId IdType="pmc">PMC7454711</ArticleId><ArticleId IdType="pubmed">32885126</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Guijarro C, Torres-Macho J, Velasco-Arribas M, Plaza-Canteli S, Hern&#xe1;ndez-Barrera V, et al. . Diabetes and the risk of long-term post-COVID symptoms. Diabetes (2021) 70:2917&#x2013;21. doi: 10.2337/db21-0329</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db21-0329</ArticleId><ArticleId IdType="pubmed">34580087</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell (2022) 185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med (2020) 8:e46&#x2013;47. doi: 10.1016/S2213-2600(20)30216-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30216-2</ArticleId><ArticleId IdType="pmc">PMC7185942</ArticleId><ArticleId IdType="pubmed">32353251</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosmann M. Complement control for COVID-19. Sci Immunol (2021) 6:eabj1014. doi: 10.1126/sciimmunol.abj1014</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abj1014</ArticleId><ArticleId IdType="pmc">PMC8432947</ArticleId><ArticleId IdType="pubmed">34035117</ArticleId></ArticleIdList></Reference><Reference><Citation>An AY, Baghela AS, Falsafi R, Lee AH, Trahtemberg U, Baker AJ, et al. . Severe COVID-19 and non-COVID-19 severe sepsis converge transcriptionally after a week in the intensive care unit, indicating common disease mechanisms. Front Immunol (2023) 6:1167917. doi: 10.3389/fimmu.2023.1167917</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1167917</ArticleId><ArticleId IdType="pmc">PMC10115984</ArticleId><ArticleId IdType="pubmed">37090709</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, John Wherry E. T cell responses in patients with COVID-19. Nat Rev Immunol (2020) 20:529&#x2013;36. doi: 10.1038/s41577-020-0402-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0402-6</ArticleId><ArticleId IdType="pmc">PMC7389156</ArticleId><ArticleId IdType="pubmed">32728222</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Liao X, Song X, He M, Xiao F, Jin X, et al. . Severe adaptive immune suppression may be why patients with severe COVID-19 cannot be discharged from the ICU even after negative viral tests. Front Immunol (2021) 12:755579. doi: 10.3389/fimmu.2021.755579</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.755579</ArticleId><ArticleId IdType="pmc">PMC8640185</ArticleId><ArticleId IdType="pubmed">34867988</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Yang X, Wang H, Li Z, Deng H, Liu J, et al. . Analysis of the long-term impact on cellular immunity in COVID-19-recovered individuals reveals a profound NKT cell impairment. mBio (2021) 12:e00085&#x2013;21. doi: 10.1128/mBio.00085-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00085-21</ArticleId><ArticleId IdType="pmc">PMC8092197</ArticleId><ArticleId IdType="pubmed">33906918</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, et al. . Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep (2021) 36:109518. doi: 10.1016/j.celrep.2021.109518</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Files JK, Boppana S, Perez MD, Sarkar S, Lowman KE, Qin K, et al. . Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection. J Clin Invest (2021) 131:e140491. doi: 10.1172/JCI140491</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140491</ArticleId><ArticleId IdType="pmc">PMC7773371</ArticleId><ArticleId IdType="pubmed">33119547</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>